Table 1.

Outcomes in Individuals Undergoing Gynecologic Procedures^*,^†

Procedure	Any Complication			Complications Other Than Transfusion		Transfusion		Length of Stay [Median (IQR)]
	Cisgender	TGD	TGD vs Cisgender	Cisgender	TGD	Cisgender	TGD	Cisgender	TGD
Hysterectomy	194,296 (8.3)	281 (5.2)	0.64 (0.52–0.79)	156,797 (6.7)	264 (4.9)	56,660 (2.4)	52 (1.0)	0 (0–0.4)	0 (0–0)
Oophorectomy	40,013 (4.2)	32 (6.2)	1.30 (0.68–2.48)	36,741 (3.8)	32 (6.2)	5,336 (0.6)	—‡	0 (0–0)	0 (0–0)
Vaginectomy	2,124 (20.3)	78 (37.1)	0.59 (0.21–1.67)	2,098 (20.0)	73 (34.7)	149 (1.4)	16 (7.6)	0 (0–0)	4.2 (0.7–5.0)
Vaginoplasty	2,112 (11.1)	554 (16.5)	1.85 (1.22–2.81)	2,095 (11.0)	489 (14.6)	26 (0.1)	95 (2.8)	0 (0–0)	2.5 (2.0–3.8)
Clitoroplasty–labiaplasty	425 (30.3)	75 (21.9)	0.52 (0.31–0.88)	424 (30.2)	75 (21.9)	—‡	—‡	0 (0–0)	0 (0–0)

IQR, interquartile range; TGD, transgender and gender-diverse.

Data are n (%) or adjusted odds ratio (95% CI) unless otherwise specified.

^*For patients undergoing multiple procedures, the hierarchy of hysterectomy then oophorectomy then vaginectomy then vaginoplasty then clitoroplasty–labiaplasty was applied.

^†Logistic regression models were fit to examine the association between TGD individuals and any complication separately for each gynecologic procedure while accounting for weight and sampling design. Covariates included TGD vs cisgender; age; year; race and ethnicity; insurance status; income status; hospital bed size, location, and teaching status; region; and comorbidity score. For hysterectomy, the model was further adjusted for route of hysterectomy and concomitant oophorectomy, vaginectomy, vaginoplasty, clitoroplasty–labiaplasty, anterior or posterior repair, incontinence repair, and colpopexy. For vaginectomy, the model did not include insurance status due to small cell size, and it was further adjusted for concomitant vaginoplasty. For vaginoplasty, the model was further adjusted for concomitant clitoroplasty–labiaplasty.

^‡Data suppressed due to small cell size (fewer than 10).